Literature DB >> 32726880

Unraveling exhaustion in adaptive and conventional NK cells.

Aimee M Merino1, Hansol Kim1, Jeffrey S Miller1, Frank Cichocki1.   

Abstract

Immune exhaustion in T cells significantly impacts their ability to control malignancies and infections, and its discovery has led to revolutionary therapies for cancer in the form of checkpoint blockade. NK cells, like T cells, are lymphocytes that recognize virally infected and malignantly transformed cells. However, it remains unclear if NK cells are similarly susceptible to exhaustion. In this review, the aims are to summarize what is currently known and to identify key areas of variability that skew the scientific literature on NK cell exhaustion. A lack of consensus on the defining features of NK cell dysfunctional states such as senescence, suppression, and exhaustion has made a comparison between studies difficult. There are also significant differences in the biology of NK cell subsets with long-lived, adaptive NK cells sharing an epigenetic signature closer to memory CD8+  T cells than to conventional NK cells. Very different checkpoint receptor expression and effector functions have been shown in adaptive versus conventional NK cells chronically exposed to activating signals. Adaptive NK cells develop in individuals with cytomegalovirus (CMV) infection and well over half of the human population worldwide is CMV seropositive by adulthood. Despite this high prevalence, most studies do not account or control for this population. This may contribute to some of the variability reported in the literature on checkpoint receptor expression on NK cells. In this review, the protective role that exhaustion plays in T cells will also be discussed and the evidence for a similar phenomenon in NK cells will be examined. ©2020 Society for Leukocyte Biology.

Entities:  

Keywords:  Exhaustion; LAG-3; Natural Killer; PD-1; adaptive; checkpoint receptor

Mesh:

Year:  2020        PMID: 32726880      PMCID: PMC7722010          DOI: 10.1002/JLB.4MR0620-091R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  85 in total

Review 1.  Immunometabolism and natural killer cell responses.

Authors:  Katie L O'Brien; David K Finlay
Journal:  Nat Rev Immunol       Date:  2019-05       Impact factor: 53.106

2.  Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade.

Authors:  Joy Hsu; Jonathan J Hodgins; Malvika Marathe; Chris J Nicolai; Marie-Claude Bourgeois-Daigneault; Troy N Trevino; Camillia S Azimi; Amit K Scheer; Haley E Randolph; Thornton W Thompson; Lily Zhang; Alexandre Iannello; Nikhita Mathur; Karen E Jardine; Georgia A Kirn; John C Bell; Michael W McBurney; David H Raulet; Michele Ardolino
Journal:  J Clin Invest       Date:  2018-09-10       Impact factor: 14.808

Review 3.  Natural Killer Cell Memory.

Authors:  Timothy E O'Sullivan; Joseph C Sun; Lewis L Lanier
Journal:  Immunity       Date:  2015-10-20       Impact factor: 31.745

4.  De Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell Rejuvenation.

Authors:  Hazem E Ghoneim; Yiping Fan; Ardiana Moustaki; Hossam A Abdelsamed; Pradyot Dash; Pranay Dogra; Robert Carter; Walid Awad; Geoff Neale; Paul G Thomas; Ben Youngblood
Journal:  Cell       Date:  2017-06-22       Impact factor: 41.582

5.  Transcriptional mechanisms underlying lymphocyte tolerance.

Authors:  Fernando Macián; Francisco García-Cózar; Sin-Hyeog Im; Heidi F Horton; Michael C Byrne; Anjana Rao
Journal:  Cell       Date:  2002-06-14       Impact factor: 41.582

6.  LAG-3, a novel lymphocyte activation gene closely related to CD4.

Authors:  F Triebel; S Jitsukawa; E Baixeras; S Roman-Roman; C Genevee; E Viegas-Pequignot; T Hercend
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

7.  Continuous activity of Foxo1 is required to prevent anergy and maintain the memory state of CD8+ T cells.

Authors:  Arnaud Delpoux; Rodrigo Hess Michelini; Shilpi Verma; Chen-Yen Lai; Kyla D Omilusik; Daniel T Utzschneider; Alec J Redwood; Ananda W Goldrath; Chris A Benedict; Stephen M Hedrick
Journal:  J Exp Med       Date:  2017-12-27       Impact factor: 14.307

8.  Inhibition of immune checkpoints PD-1, CTLA-4, and IDO1 coordinately induces immune-mediated liver injury in mice.

Authors:  Timothy Affolter; Heather P Llewellyn; Derek W Bartlett; Qing Zong; Shuhua Xia; Vince Torti; Changhua Ji
Journal:  PLoS One       Date:  2019-05-21       Impact factor: 3.240

9.  PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression.

Authors:  Francesca R Mariotti; Stefania Petrini; Tiziano Ingegnere; Nicola Tumino; Francesca Besi; Francesca Scordamaglia; Enrico Munari; Silvia Pesce; Emanuela Marcenaro; Alessandro Moretta; Paola Vacca; Lorenzo Moretta
Journal:  Oncoimmunology       Date:  2018-12-25       Impact factor: 8.110

10.  Critical Role of CD2 Co-stimulation in Adaptive Natural Killer Cell Responses Revealed in NKG2C-Deficient Humans.

Authors:  Lisa L Liu; Johannes Landskron; Eivind H Ask; Monika Enqvist; Ebba Sohlberg; James A Traherne; Quirin Hammer; Jodie P Goodridge; Stella Larsson; Jyothi Jayaraman; Vincent Y S Oei; Marie Schaffer; Kjetil Taskén; Hans-Gustaf Ljunggren; Chiara Romagnani; John Trowsdale; Karl-Johan Malmberg; Vivien Béziat
Journal:  Cell Rep       Date:  2016-04-21       Impact factor: 9.423

View more
  12 in total

Review 1.  Epi-immunotherapy for cancers: rationales of epi-drugs in combination with immunotherapy and advances in clinical trials.

Authors:  Yang Xu; Ping Li; Yang Liu; Dijia Xin; Wen Lei; Aibin Liang; Weidong Han; Wenbin Qian
Journal:  Cancer Commun (Lond)       Date:  2022-06-01

Review 2.  Leveraging NKG2D Ligands in Immuno-Oncology.

Authors:  Mercedes Beatriz Fuertes; Carolina Inés Domaica; Norberto Walter Zwirner
Journal:  Front Immunol       Date:  2021-07-29       Impact factor: 7.561

3.  Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival.

Authors:  Carlo Sorrentino; Luigi D'Antonio; Cristiano Fieni; Stefania Livia Ciummo; Emma Di Carlo
Journal:  Front Immunol       Date:  2021-12-16       Impact factor: 7.561

Review 4.  NK Cells in a Tug-of-War With Cancer: The Roles of Transcription Factors and Cytoskeleton.

Authors:  E Hui Clarissa Lee; Darren Chen Pei Wong; Jeak Ling Ding
Journal:  Front Immunol       Date:  2021-09-14       Impact factor: 7.561

Review 5.  Natural killer cells and immune-checkpoint inhibitor therapy: Current knowledge and new challenges.

Authors:  Alessandro Poggi; Maria Raffaella Zocchi
Journal:  Mol Ther Oncolytics       Date:  2021-11-29       Impact factor: 7.200

6.  Reevaluation of NOD/SCID Mice as NK Cell-Deficient Models.

Authors:  Miao Miao; Henry Masengere; Guang Yu; Fengping Shan
Journal:  Biomed Res Int       Date:  2021-11-10       Impact factor: 3.411

Review 7.  Making a Killer: Selecting the Optimal Natural Killer Cells for Improved Immunotherapies.

Authors:  Samantha A Barnes; Isabella Trew; Emma de Jong; Bree Foley
Journal:  Front Immunol       Date:  2021-10-27       Impact factor: 7.561

8.  Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity.

Authors:  Congcong Zhang; Jasmin Röder; Anne Scherer; Malena Bodden; Jordi Pfeifer Serrahima; Anita Bhatti; Anja Waldmann; Nina Müller; Pranav Oberoi; Winfried S Wels
Journal:  J Immunother Cancer       Date:  2021-10       Impact factor: 13.751

Review 9.  Taking Lessons from CAR-T Cells and Going Beyond: Tailoring Design and Signaling for CAR-NK Cells in Cancer Therapy.

Authors:  Katharina Eva Ruppel; Stephan Fricke; Ulrike Köhl; Dominik Schmiedel
Journal:  Front Immunol       Date:  2022-03-18       Impact factor: 7.561

Review 10.  A Hot Topic: Cancer Immunotherapy and Natural Killer Cells.

Authors:  Tatiana Michel; Markus Ollert; Jacques Zimmer
Journal:  Int J Mol Sci       Date:  2022-01-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.